Torrent Pharmaceuticals Share Price

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. As of 14 Jun 2026, Torrent Pharmaceuticals share price is ₹4,571.20. The stock opened at ₹4,619.50, compared to its previous close of ₹4,572.20. During today's trading session, Torrent Pharmaceuticals share price moved in the range of ₹4,557.90 to ₹4,666.00, with an average price of ₹4,611.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,557.90 and a high of ₹4,666.00. On the performance front, Torrent Pharmaceuticals share price has increased by 20.56% over the last six months and is up 40.27% on a year-on-year basis.

The market capitalization of Torrent Pharmaceuticals is ₹1,54,837 Crs, with a P/E ratio of 66.0 and a dividend yield of 0.90%.